Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation

Abstract Several recent studies have established the efficacy of photobiomodulation therapy (PBMT) in painful clinical conditions. Diabetic neuropathy (DN) can be related to activating mitogen-activated protein kinases (MAPK), such as p38, in the peripheral nerve. MAPK pathway is activated in respon...

Full description

Bibliographic Details
Main Authors: Willians Fernando Vieira, Kauê Franco Malange, Silviane Fernandes de Magalhães, Júlia Borges Paes Lemes, Gilson Gonçalves dos Santos, Catarine Massucato Nishijima, Alexandre Leite Rodrigues de Oliveira, Maria Alice da Cruz-Höfling, Cláudia Herrera Tambeli, Carlos Amilcar Parada
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-19947-2
_version_ 1797996120640585728
author Willians Fernando Vieira
Kauê Franco Malange
Silviane Fernandes de Magalhães
Júlia Borges Paes Lemes
Gilson Gonçalves dos Santos
Catarine Massucato Nishijima
Alexandre Leite Rodrigues de Oliveira
Maria Alice da Cruz-Höfling
Cláudia Herrera Tambeli
Carlos Amilcar Parada
author_facet Willians Fernando Vieira
Kauê Franco Malange
Silviane Fernandes de Magalhães
Júlia Borges Paes Lemes
Gilson Gonçalves dos Santos
Catarine Massucato Nishijima
Alexandre Leite Rodrigues de Oliveira
Maria Alice da Cruz-Höfling
Cláudia Herrera Tambeli
Carlos Amilcar Parada
author_sort Willians Fernando Vieira
collection DOAJ
description Abstract Several recent studies have established the efficacy of photobiomodulation therapy (PBMT) in painful clinical conditions. Diabetic neuropathy (DN) can be related to activating mitogen-activated protein kinases (MAPK), such as p38, in the peripheral nerve. MAPK pathway is activated in response to extracellular stimuli, including interleukins TNF-α and IL-1β. We verified the pain relief potential of PBMT in streptozotocin (STZ)-induced diabetic neuropathic rats and its influence on the MAPK pathway regulation and calcium (Ca2+) dynamics. We then observed that PBMT applied to the L4-L5 dorsal root ganglion (DRG) region reduced the intensity of hyperalgesia, decreased TNF-α and IL-1β levels, and p38-MAPK mRNA expression in DRG of diabetic neuropathic rats. DN induced the activation of phosphorylated p38 (p-38) MAPK co-localized with TRPV1+ neurons; PBMT partially prevented p-38 activation. DN was related to an increase of p38-MAPK expression due to proinflammatory interleukins, and the PBMT (904 nm) treatment counteracted this condition. Also, the sensitization of DRG neurons by the hyperglycemic condition demonstrated during the Ca2+ dynamics was reduced by PBMT, contributing to its anti-hyperalgesic effects.
first_indexed 2024-04-11T10:12:28Z
format Article
id doaj.art-109d49297c3c47e6a95d08bb0c8c9110
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T10:12:28Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-109d49297c3c47e6a95d08bb0c8c91102022-12-22T04:30:04ZengNature PortfolioScientific Reports2045-23222022-10-0112111810.1038/s41598-022-19947-2Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulationWillians Fernando Vieira0Kauê Franco Malange1Silviane Fernandes de Magalhães2Júlia Borges Paes Lemes3Gilson Gonçalves dos Santos4Catarine Massucato Nishijima5Alexandre Leite Rodrigues de Oliveira6Maria Alice da Cruz-Höfling7Cláudia Herrera Tambeli8Carlos Amilcar Parada9Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP)Abstract Several recent studies have established the efficacy of photobiomodulation therapy (PBMT) in painful clinical conditions. Diabetic neuropathy (DN) can be related to activating mitogen-activated protein kinases (MAPK), such as p38, in the peripheral nerve. MAPK pathway is activated in response to extracellular stimuli, including interleukins TNF-α and IL-1β. We verified the pain relief potential of PBMT in streptozotocin (STZ)-induced diabetic neuropathic rats and its influence on the MAPK pathway regulation and calcium (Ca2+) dynamics. We then observed that PBMT applied to the L4-L5 dorsal root ganglion (DRG) region reduced the intensity of hyperalgesia, decreased TNF-α and IL-1β levels, and p38-MAPK mRNA expression in DRG of diabetic neuropathic rats. DN induced the activation of phosphorylated p38 (p-38) MAPK co-localized with TRPV1+ neurons; PBMT partially prevented p-38 activation. DN was related to an increase of p38-MAPK expression due to proinflammatory interleukins, and the PBMT (904 nm) treatment counteracted this condition. Also, the sensitization of DRG neurons by the hyperglycemic condition demonstrated during the Ca2+ dynamics was reduced by PBMT, contributing to its anti-hyperalgesic effects.https://doi.org/10.1038/s41598-022-19947-2
spellingShingle Willians Fernando Vieira
Kauê Franco Malange
Silviane Fernandes de Magalhães
Júlia Borges Paes Lemes
Gilson Gonçalves dos Santos
Catarine Massucato Nishijima
Alexandre Leite Rodrigues de Oliveira
Maria Alice da Cruz-Höfling
Cláudia Herrera Tambeli
Carlos Amilcar Parada
Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
Scientific Reports
title Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
title_full Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
title_fullStr Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
title_full_unstemmed Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
title_short Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation
title_sort anti hyperalgesic effects of photobiomodulation therapy 904 nm on streptozotocin induced diabetic neuropathy imply mapk pathway and calcium dynamics modulation
url https://doi.org/10.1038/s41598-022-19947-2
work_keys_str_mv AT williansfernandovieira antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT kauefrancomalange antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT silvianefernandesdemagalhaes antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT juliaborgespaeslemes antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT gilsongoncalvesdossantos antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT catarinemassucatonishijima antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT alexandreleiterodriguesdeoliveira antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT mariaalicedacruzhofling antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT claudiaherreratambeli antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation
AT carlosamilcarparada antihyperalgesiceffectsofphotobiomodulationtherapy904nmonstreptozotocininduceddiabeticneuropathyimplymapkpathwayandcalciumdynamicsmodulation